- Home
- BNL vs CRNX Comparison
BNL vs CRNX Comparison
Compare BNL & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNL
- CRNX
- Stock Information
- Founded
- BNL 2007
- CRNX 2008
- Country
- BNL United States
- CRNX United States
- Employees
- BNL N/A
- CRNX N/A
- Industry
- BNL Real Estate Investment Trusts
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- BNL Real Estate
- CRNX Health Care
- Exchange
- BNL Nasdaq
- CRNX Nasdaq
- Market Cap
- BNL 3.1B
- CRNX 2.8B
- IPO Year
- BNL 2020
- CRNX 2018
- Fundamental
- Price
- BNL $16.27
- CRNX $30.50
- Analyst Decision
- BNL Hold
- CRNX Strong Buy
- Analyst Count
- BNL 5
- CRNX 10
- Target Price
- BNL $18.40
- CRNX $75.00
- AVG Volume (30 Days)
- BNL 1.9M
- CRNX 699.1K
- Earning Date
- BNL 07-29-2025
- CRNX 08-07-2025
- Dividend Yield
- BNL 7.12%
- CRNX N/A
- EPS Growth
- BNL N/A
- CRNX N/A
- EPS
- BNL 0.60
- CRNX N/A
- Revenue
- BNL $435,124,000.00
- CRNX $760,000.00
- Revenue This Year
- BNL $4.15
- CRNX $402.12
- Revenue Next Year
- BNL $5.26
- CRNX $770.88
- P/E Ratio
- BNL $27.13
- CRNX N/A
- Revenue Growth
- BNL 1.37
- CRNX N/A
- 52 Week Low
- BNL $13.96
- CRNX $24.10
- 52 Week High
- BNL $19.15
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- BNL 55.50
- CRNX 43.00
- Support Level
- BNL $15.85
- CRNX $32.05
- Resistance Level
- BNL $16.17
- CRNX $33.77
- Average True Range (ATR)
- BNL 0.29
- CRNX 1.14
- MACD
- BNL 0.02
- CRNX -0.12
- Stochastic Oscillator
- BNL 74.10
- CRNX 28.13
About BNL Broadstone Net Lease Inc.
Broadstone Net Lease Inc is an internally managed real estate investment trust that invests in, owns, and manages single-tenant commercial real estate properties that are net leased on a long-term basis to a diversified group of tenants. The company has selectively invested in net leased assets in the industrial, healthcare, restaurant, retail, and office property types. The company focuses on investing in real estate that is operated by creditworthy single tenants in industries characterized by positive business drivers and trends. The company targets properties that are an integral part of the tenants' businesses and are therefore opportunities to secure long-term net leases.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.